Stuart Chipkin to Hypoglycemic Agents
This is a "connection" page, showing publications Stuart Chipkin has written about Hypoglycemic Agents.
Connection Strength
0.495
-
Chipkin SR. How to select and combine oral agents for patients with type 2 diabetes mellitus. Am J Med. 2005 May; 118 Suppl 5A:4S-13S.
Score: 0.199
-
Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg. 2011 Sep; 254(3):458-63; discussion 463-4.
Score: 0.077
-
Malin SK, Stephens BR, Sharoff CG, Hagobian TA, Chipkin SR, Braun B. Metformin's effect on exercise and postexercise substrate oxidation. Int J Sport Nutr Exerc Metab. 2010 Feb; 20(1):63-71.
Score: 0.069
-
Sharoff CG, Hagobian TA, Malin SK, Chipkin SR, Yu H, Hirshman MF, Goodyear LJ, Braun B. Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals. Am J Physiol Endocrinol Metab. 2010 Apr; 298(4):E815-23.
Score: 0.069
-
Braun B, Eze P, Stephens BR, Hagobian TA, Sharoff CG, Chipkin SR, Goldstein B. Impact of metformin on peak aerobic capacity. Appl Physiol Nutr Metab. 2008 Feb; 33(1):61-7.
Score: 0.060
-
Malin SK, Nightingale J, Choi SE, Chipkin SR, Braun B. Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults. Obesity (Silver Spring). 2013 Jan; 21(1):93-100.
Score: 0.021